The authors found that L1 MI was significantly higher in patients with both early (I/II) and advanced (III/IV) CRC stages compared to healthy donors, and showed that L1 MI surpassed CEA in the detection of early-stage CRC and had a similar sensitivity for advanced-stage CRC. The gene discussed is CEACAM5; the disease is colorectal carcinoma.